|
WHO Model List of Essential Medicines (2021)
|
8.2.1 Cytotoxic medicines
|
No observations
|
|
PAHO Strategic Fund Medicine List
|
3.2. Cytotoxic medicines
|
Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
|
|
Peru
|
8.2 Cytotoxics
|
No observations
|
|
Ecuador
|
Essential Medicines List - Ecuador
|
No observations
|
|
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.
|
CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.
|
Others observations:
BBO X 2ML
|
|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.
|
Antitumor Antibiotics
|
No observations
|
|
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020
|
01 AGENTES ANTINEOPLÁSICOS
|
No observations
|
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
41. Antineoplásicos y agentes inmunomoduladores
|
No observations
|
|
Suriname. NGK-C-011
|
8.2 Cytotoxic Agents
|
No observations
|
|
Haiti. National List of Essential Medicines
|
08.02 Cytotoxic and adjuvant drugs
|
No observations
|
